학술논문

A phase I study of enfortumab vedotin in Japanese patients with locally advanced or metastatic urothelial carcinoma.
Document Type
Article
Source
Investigational New Drugs; Aug2020, Vol. 38 Issue 4, p1056-1066, 11p
Subject
CANCER chemotherapy
THERAPEUTIC use of monoclonal antibodies
BLADDER tumors
CANCER patients
CANCER relapse
DOSE-effect relationship in pharmacology
DRUG side effects
METASTASIS
MONOCLONAL antibodies
PATIENT safety
STATISTICAL sampling
URINARY organs
RANDOMIZED controlled trials
RECEIVER operating characteristic curves
DESCRIPTIVE statistics
Language
ISSN
01676997
Abstract
Copyright of Investigational New Drugs is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)